Literature DB >> 1358253

Antianxiety properties of the angiotensin II antagonist, DUP 753, in the rat using the elevated plus-maze.

F C Kaiser1, G C Palmer, A V Wallace, R D Carr, L Fraser-Rae, C Hallam.   

Abstract

The angiotensin II receptor antagonist, DUP 753 (Losartan), was compared with diazepam for antianxiety properties in the rat using the elevated plus-maze. Oral diazepam (5 mg kg-1) resulted in a significantly greater number of entries of rats into the open arms of the maze, an increase in time spent in the open arms and a decreased time spent in the closed arms. Oral doses of DUP 753 likewise resulted in significantly greater numbers of entries into the open arms (active at 0.0001, 0.001, 0.01 and 0.1 mg kg-1), increased time spent on the open arms (active at 0.0001-0.01 mg kg-1) and a decreased time spent in the closed arms (active at 0.0001, 0.01 and 0.1 mg kg-1). Larger (1.0 mg kg-1) or smaller (0.00001 mg kg-1) doses of DUP 753 were not active.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1358253     DOI: 10.1097/00001756-199210000-00026

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  9 in total

Review 1.  Angiotensin II AT(1) receptor blockers ameliorate inflammatory stress: a beneficial effect for the treatment of brain disorders.

Authors:  Juan M Saavedra
Journal:  Cell Mol Neurobiol       Date:  2011-09-22       Impact factor: 5.046

Review 2.  Blockade of brain angiotensin II AT1 receptors ameliorates stress, anxiety, brain inflammation and ischemia: Therapeutic implications.

Authors:  Juan M Saavedra; Enrique Sánchez-Lemus; Julius Benicky
Journal:  Psychoneuroendocrinology       Date:  2010-10-29       Impact factor: 4.905

Review 3.  Angiotensin II AT(1) receptor blockers as treatments for inflammatory brain disorders.

Authors:  Juan M Saavedra
Journal:  Clin Sci (Lond)       Date:  2012-11       Impact factor: 6.124

4.  Effects of the selective angiotensin II receptor antagonists losartan and PD123177 in animal models of anxiety and memory.

Authors:  J Shepherd; D J Bill; C T Dourish; S S Grewal; A McLenachan; K J Stanhope
Journal:  Psychopharmacology (Berl)       Date:  1996-08       Impact factor: 4.530

5.  Telmisartan ameliorates glutamate-induced neurotoxicity: roles of AT(1) receptor blockade and PPARγ activation.

Authors:  Juan Wang; Tao Pang; Roman Hafko; Julius Benicky; Enrique Sanchez-Lemus; Juan M Saavedra
Journal:  Neuropharmacology       Date:  2013-12-04       Impact factor: 5.250

6.  Angiotensin II's role in sodium lactate-induced panic-like responses in rats with repeated urocortin 1 injections into the basolateral amygdala: amygdalar angiotensin receptors and panic.

Authors:  Philip L Johnson; Tammy J Sajdyk; Stephanie D Fitz; Mathew W Hale; Christopher A Lowry; Anders Hay-Schmidt; Anantha Shekhar
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2013-03-21       Impact factor: 5.067

7.  Evidence that the anxiolytic-like effects of chlordiazepoxide on the elevated plus maze are confounded by increases in locomotor activity.

Authors:  G R Dawson; S P Crawford; N Collinson; S D Iversen; M D Tricklebank
Journal:  Psychopharmacology (Berl)       Date:  1995-04       Impact factor: 4.530

8.  Ability of angiotensin II to modulate striatal dopamine release via the AT1 receptor in vitro and in vivo.

Authors:  D C Brown; L J Steward; J Ge; N M Barnes
Journal:  Br J Pharmacol       Date:  1996-05       Impact factor: 8.739

9.  Fear-potentiated behaviour is modulated by central amygdala angiotensin II AT1 receptors stimulation.

Authors:  Maria de los Angeles Marinzalda; Pablo A Pérez; Pascual A Gargiulo; Brenda S Casarsa; Claudia Bregonzio; Gustavo Baiardi
Journal:  Biomed Res Int       Date:  2014-06-09       Impact factor: 3.411

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.